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Abstract of thesis entitled: 
Human Bone Marrow Stromal Cells have Mitogenic 
Activity on SK-Hep-1 cells 
Submitted by Siu, Yeung Tung for the degree of Master of Philosophy in Surgery at 
The Chinese University of Hong Kong in Jan, 2001. 
The rapid regulation of growth factors including hepatocyte growth factor, 
interleukin-6 and epidermal growth factor are essential in triggering quiescent 
hepatocytes to proliferate after liver injury. However, direct infusion of above 
cytokines only have a little effect on hepatic DNA synthesis indicating that other 
mitogenic signal is responsible for the initiation of hepatocytes proliferation in vivo. 
It has been shown that hepatocytes can arise from a cell population originating in the 
bone marrow, and bone marrow stromal cells serve an important role in bone marrow 
cell proliferation and differentiation. Thus, it was speculated that bone marrow 
stromal cells may also play a role in regulating hepatocytes proliferation. In this 
project, SK-Hep-1 cells were selected for the detection of the mitogenic activity of 
human bone marrow stromal cells from five hepatic cell lines, Hep 3B, Hep G2, 
C3A, SK-Hep-1 and Chang cells because of its ability to be growth arrested. It was 
demonstrated that human bone marrow stromal cellular extracts exhibited mitogenic 
activity on partially growth arrested SK-Hep-1 cells in a dosage dependent manner. 
The major mitogenic activity of the stromal cellular extract was protein in nature as 
shown in its sensitivity to heat and proteinase treatment. In conclusion, human bone 
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Chapter 1 Introduction 
1.1 Growth factors involved in hepatocytes proliferation 
Mature hepatocytes are quiescent and highly differentiated liver cells. During liver 
regeneration, these mature hepatocytes are first to proliferate followed by the growth 
of other mature liver cell populations including biliary ductular cells, Kupffer cells, 
Ito cells and sinusoidal endothelial cells after partial hepatectomy (PHx) or hepatic 
toxins injury. These proliferating hepatocytes produce growth factors leading to the 
growth of other liver cell populations by paracrine mechanism. The growth factors 
involved in hepatocytes proliferation during liver regeneration were described 
(Michalopoulos and DeFrances, 1997). These include hepatocyte growth factor 
(HGF)� tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6), epidermal growth 
factor (EGF)� transforming growth factor-a (TGF-a) and transforming growth 
factor-P (TGF-P). The entire process of proliferation is precisely regulated and once 
the proportional liver mass is attained, hepatocytes revert to their growth arrested 
state. 
1.1.1 Hepatocyte growth factor (HGF) 
The hepatocyte growth factor / scatter factor (SF) and its receptor c-Met (Naldini et 
al.，1991) are the key factors in early signaling pathway of hepatocyte proliferation. 
The HGF is the most potent hepatocyte mitogen in vitro and in vivo (Nakamura et al., 
1989). After PHx, dramatically translocation of urokinase receptor (uPA-R) to 
hepatic plasma membrane within 1 min resulting in enhanced activity of urokinase 
(uPA) (Mars et a l , 1995). The activated uPA converts plasminogen into plasmin， 
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which in turn activates matrix degrading metalloproteases. The activated 
metalloproteases participate in proteolysis of hepatic biomatrix, which is a source 
rich of matrix-bound inactive single-chain from HGF (pro-HGF) (Rifkin, 1992; 
Blasi, 1993). The released pro-HGF was also activated by uPA into active two-chain 
form HGF, the high affinity ligand for the c-Met receptor through the extracellular 
hydrolysis of the Arg494-Val495 (Mars et al., 1993; Naldini et al., 1995). This 
accounts for the plasma concentrations of HGF rises 17-fold within 2 hr after PHx in 
rat (Lindroos et al , 1991). Released HGF induces some immediate early genes, 
including liver regeneration factor-1 (LRF-1) and insulin-like growth factor binding 
protein-1 (IGFBPl) with a maximum expression 3 hr after PHx (Weir et al., 1994). 
1.1.2 Tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6) 
Both tumor necrosis factor-a and interleukin-6 are essential in early signaling 
pathway of hepatocyte proliferation. The plasma concentrations of IL-6 rises 12-fold 
after PHx in rat (Rai et al., 1996). IL-6 is secreted by Kupffer cells under the 
stimulation of TNF-a. Signal transducer and activator of transcription-3 (STATS), a 
transcription factor for many immediate-early genes, involving in hepatocytes 
proliferation, can be activated by IL-6. DNA synthesis and STATS activity after 
PHx are severely impaired in mice with TNF-a type I receptor deficiency. Injection 
of IL-6 before PHx corrects this defect (Yamada et al., 1997). The DNA synthesis of 
hepatocyte during liver regeneration is suppressed in mice with a homozygous 
deletion of the IL-6 gene (Cressman et al., 1996). However the mitogenic effect of 
IL-6 on cultured hepatocytes cannot be determined as both stimulating (Kuma et a l , 
1990) and inhibiting (Kordula et al , 1991) effect had been reported. 
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1.1.3 Epidermal growth factor (EGF) and transforming growth factor-a 
(TGF-a) 
Epidermal growth factor (EGF) is involving in early signaling pathway of 
hepatocytes proliferation while transforming growth factors-a (TGF-a) involves at a 
latter time. TGF-a belongs to the EGF/TGF-a family and shares 35 % sequence 
homology with EGF and nearly identical spectrum of biological activities with EGF 
(Massague, 1990). Both EGF and TGF-a bind to the epidermal growth factor 
receptor (EGFR) on hepatocytes (Massague, 1990). Both EGF and TGF-a are 
mitogens for cultured hepatocytes. EGF is continually made available to the 
hepatocytes by salivary glands or Brunner's glands of the duodenum (Skov et al.， 
1988). There is about 20 % increased in plasma concentrations of EGF after PHx in 
rat (Noguchi et al., 1991). Removal of salivary gland delays the peak of DNA 
synthesis of hepatocytes after PHx in rat and such defect can be restored by the 
administration of EGF (Jones, Jr. et al., 1995). Rapid tyrosine phosphorylation of 
EGF receptor occurs shortly after PHx suggesting that EGF involved in the early 
hepatocytes proliferation (Rubin et al , 1982). There is about 9-fold increased in 
TGF-a mRNA expression in hepatocytes 24 hr after PHx (Mead and Fausto, 1989). 
But there is only a small rise in plasma concentrations of TGF-a after PHx (Tomiya 
and Fujiwara, 1996a; Tomiya and Fujiwara, 1996b). This suggests that TGF-a is 
made available to hepatocytes through autocrine amplification mechanism in a latter 
stage of hepatocytes proliferation. TGF-a secreted from hepatocytes is also acted as 
mitogen for the surroundings endothelial cells such as biliary ductular cells. DNA 
synthesis in those endothelial cells starts 24 hr after PHx (Michalopoulos and 
DeFrances, 1997). That is the time of TGF-a being expressed by hepatocytes after 
PHx suggesting that hepatocytes stimulate proliferation of other liver cell 
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populations by a paracrine mechanism. Acidic fibroblast growth factor/Heparin-
binding growth factor type I (FGF/HBGF-1) (Kan et al.，1989) and vascular 
endothelial growth factor (VEGF) (Mochida et a l , 1996) are also secreted by 
proliferating hepatocytes that can also trigger mitosis of other liver cell populations. 
Interestingly, the DNA synthesis of hepatocytes during liver regeneration proceeds 
normally in mice with a homozygous deletion of the TGF-a gene (Russell et al , 
1996). This may be compensated by the increase in other ligands in EGF receptor 
family. 
1.1.4 Other comitogens 
There are other factors, by itself, having no significant proliferative effect on 
hepatocytes. However these comitogens can synergistically enhance the stimulatory 
effect of hepatocyte mitogens. They include hormones and neurotransmitters, such 
as insulin, glucagon, insulin-like growth factors, norepinephrine, thyroid hormones 
and hepatic stimulatory substance (HSS) (Steer, 1995; Michalopoulos and 
DeFrances, 1997). However most of their functions and regulatory pathways in 
hepatocytes proliferation are unknown. 
In fact, more than 70 immediate-early genes in hepatocytes have been identified after 
PHx，41 of which are novel (Haber et a l , 1993). Infusion ofHGF, EGF and TGF-a 
in normal rat directly through the portal vein can only have a little effect on hepatic 
DNA synthesis (Webber et a l , 1994). This indicates that other mitogenic signal is 
required for hepatocytes to leave quiescent state. 
4 ‘ 
1.1.5 Transforming growth factor-P (TGF-P) 
After PHx, the regenerating liver attained its original mass, and hepatocytes revert to 
their growth arrested state and stop growing. Transforming growth factor-P (TGF-P) 
secreted by Ito cells inhibits DNA synthesis in hepatocytes in vitro and in vivo (Carr 
et al.，1986; Russell et al , 1988). The expression of TGF-p receptor on hepatocytes 
decreases to the lowest level 24 hr after PHx (Chari et al., 1995). While TGF-P 
mRNA level continues increasing with a plateau at about 48 hr (Braun et al., 1988). 
The expression of TGF-p receptor recovers to 60 % of pre-PHx level 120 hr after 
PHx. This down regulation of TGF-P receptor allows the hepatocytes to proliferate 
while the TGF-p level is increasing. There is no other specific hepatocyte growth 
inhibitor was known. 
Major growth factors that involved in hepatocytes proliferation during liver 
regeneration were summarized in the table 1 (Michalopoulos and DeFrances, 1997). 
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Table 1. Growth factors and receptor interactions during liver regeneration 
Growth factor Source of growth Receptor Location of Activity of growth factor 
factor receptor /receptor interaction 
HGF Hepatic biomatrix c-Met Hepatocytes Mitogenic effect; key factor in 
immediate early signaling of 
DNA synthesis 
TNF-a Kupffer cells TNF-aR Kupffer cells Stimulate IL-6 secretion from 
Kupffer cells 
IL-6 Kupffer cells IL-6R Hepatocytes Essential in early signaling of 
DNA synthesis 
EGF Salivary glands or EGFR Hepatocytes Mitogenic effect; involved in 
Brunner's glands early signaling of DNA 
of duodenum synthesis 
TGF-a Hepatocytes EGFR Hepatocytes Mitogenic effect; involved in 
a latter stage of DNA 
synthesis 
TGF-P Ito cells TGF-PR Hepatocytes Inhibition on DNA synthesis; 
involved in terminal stage of 
liver regeneration 
EGF，epidermal growth factor; EGFR, epidermal growth factor receptor; HGF, hepatocyte growth 
factor; IL-6, interleukin-6; IL-6R, interleukin-6 receptor; TGF-a, transforming growth factor-a; TGF-
aR，transforming growth factor-a receptor; TGF-P, transforming growth factor-P; TGF-PR, 
transforming growth factor-P receptor; TNF-a, tumor necrosis factor-a; TNF-aR, tumor necrosis 
factor-a receptor 
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1.2 Bone marrow stromal cells and hepatocytes proliferation 
1.2.1 Role of bone marrow stromal cells in bone marrow 
Human bone marrow stromal cells provide a microenvironment to regulate and 
sustain the self-renewal and differentiation of hematopoietic stem cells. This is 
achieved through a direct interaction between stromal cells and stem cells mediated 
by adhesion molecules and growth factors released from the stromal cells 
(Dorshkind, 1990; Quesenberry, 1992). In long-term bone marrow culture 
(LTBMC), those stem cells and immature precursors adhere tightly to the stroma 
while those more mature precursors and differentiated cells are found as nonadherent 
cells (Coulombel et al.，1983; Harrison et al.，1987; Kiemey and Dorshkind, 1987). 
This suggests that the decomposition of these adhesion molecules, collagen, 
fibronectin and laminin of the extracellular biomatrix (Gallagher et al., 1983; 
Zuckerman and Wicha，1983; Campbell et al., 1985) and the release of the matrix-
bound stromal-derived factors, like granulocyte-macrophage colony-stimulating 
factor (GM-CSF) (Gordon et a l , 1987; Roberts et a l , 1988) are necessary for 
hematopoiesis. Numerous stromal-derived factors that can facilitate the proliferation 
and differentiation of hematopoietic cells are identified (Ogawa, 1993). These 
factors can be characterized into myelopoietic, erythropoietic and lymphopoietic 
factors with respect to their effect on lineage specific hematopoietic cell growth and 
differentiation. There are at least 12 lymphopoiesis regulatory stromal-derived 
cytokines produced during inflammatory episodes suggesting that stromal cells can 
response to injury by changing its pattern of cytokines production (Dainiak, 1991; 
Kincade, 1991). 
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1.2.2 Bone marrow as a source of hepatic oval cells 
When the mature hepatocytes are prevented from proliferation after PHx by exposure 
to 2-acetylaminofluorene (2-AAF), hepatic oval cells will proliferate and 
differentiate to generate new hepatocytes instead (Fausto et al.，1993; Sell, 1994; 
Thorgeirsson, 1996). Compared the phenotype of bone marrow stem cells and oval 
cells, they both express CD34 (Omori et al , 1997a), Thy-1 (Petersen et al., 1998), c-
kit ( F u j i � e t al , 1994) and flt-3 receptor mRNA (Omori et al., 1997b). The cell 
lineage capacity of bone marrow in hepatic oval cells or hepatocytes was 
investigated (Petersen et al , 1999). Cross-sex bone marrow transplantation was used 
to trace the origin of the liver cells. Recipient female rat was also treated with 2-AFF 
to block hepatocytes proliferation and then CCU, a sort of hepatic toxin, to induce 
oval cells proliferation and differentiation. It had demonstrated that Y chromosome-
positive oval cells and hepatocytes present in liver of lethally irradiated syngeneic 
female rat with bone marrow transplantation from a male rat, after 2-AAF-CCI4 
treatment by day 9 and day 13. If all oval cells that differentiate into hepatocytes 
were derived from the female recipient liver, one would expect that none of the oval 
cells or hepatocytes tested would be positive for Y chromosome. Moreover, the time 
lag between day 9 and day 13 was corresponding to the time that is required for oval 
cells to differentiate into hepatocytes. This suggests that the oval cells can arise from 
a cell population originating in the donor bone marrow and continued to differentiate 
into hepatocytes by day 13. Since one of the role of bone marrow stromal cells is to 
regulate the proliferation of bone marrow originated cells. We suspect that stromal 
cells can also play a role in regulating hepatocytes proliferation. 
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1.2.3 Growth factors secreted by bone marrow stromal cells involved in 
hepatocytes proliferation 
Secretion of cytokines may be a way to regulate hepatocytes proliferation by bone 
marrow stromal cells. In addition to GM-CSF, macrophage colony-stimulating 
factor (M-CSF), granulocyte colony-stimulating factor (G-CSF), IL-ip, IL-7, IL-11, 
and stem cell factor (SCF), stromal-derived factors also include HGF, TGF-P, TNF-
a and IL-6 which are essential factors in hepatocytes proliferation as discussed 
above. HGF, initially identified as a potent mitogen for hepatocytes, was shown to 
promote myelopoiesis through stimulating colony-forming units-granulocyte 
macrophage (CFU-GM) formation in LTBMC (Kmiecik et al., 1992; Mizuno et a l , 
1993; Galimi et a l , 1994; Nishino et al., 1995; Takai et al., 1997). Myelopoiesis can 
be down regulated by TGF-P (Cashman et al., 1990; Takai et al., 1997)，which is also 
a growth inhibitor in hepatocytes. Both stromal cells and Kupffer cells can be 
triggered by TNF-a to release IL-6 (Khoury et al , 1992; Rougier et a l , 1998). IL-6 
promotes myelopoiesis through stimulating colony formation from colony-forming 
units-granulocyte (CFU-G) and macrophage colony formation in LTBMC (Bot et a l , 
1989; Liu et a l , 1997). And IL-6 is also essential in early signaling pathway of 
hepatocytes proliferation. Some of the stromal-derived factors were shown to be 
essential in triggering quiescent hepatocytes to proliferate after liver injury. 
Therefore the potential mitogenic activity of human bone marrow stromal cells on 
hepatocytes is expected. 
The growth factors that are constitutively produced from unstimulated bone marrow 
stromal cells cultivating with serum were summarized in table 2 (Dorshkind, 1990; 
Nagao，1995; Takai et a l , 1997). 
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Table 2. The constitutively produced bone marrow stromal-derived factors 
with their major effects on different lineages of hematopoietic cells 
Lineage Growth Receptor Target cells Activity of growth factor 
specificity factor /receptor interaction 
G-CSF G-CSFR CFU-G Stimulate proliferation and 
differentiation of CFU-G 
M-CSF CSFR CFU-M, Stimulate proliferation and 
Monocytes/ differentiation of CFU-M, 
Macrophages activation of monocytes/ 
macrophages 
GM-CSF GM-CSFR CFU-GM, Stimulate proliferation and 
Neutrophils, differentiation of CFU-GM, 
CFU-Mk CFU-Mk, activation of 
neutrophils 
HGF* c-Met CFU-GM Stimulate proliferation and 
differentiation of CFU-GM 
IL-lp IL-IR Macrophages Activation of macrophages 
Myelopoietic IL-3 IL-3R CFU-GM, Stimulate proliferation and 
factors CFU-Mk differentiation of CFU-GM, 
CFU-Mk 
IL-6* IL-6R CFU-GM, Stimulate proliferation and 
CFU-M, differentiation of CFU-GM, 
CFU-Mk CFU-M, CFU-Mk 
IL-7 IL-7R Monocytes Stimulate cytokines production 
from monocytes 
IL-11 IL-llR CFU-Mk Stimulatie proliferation and 
differentiation of CFU-Mk 
SCF KIT CFU-GM, Stimulate proliferation and 
CFU-Mk differentiation of CFU-GM, 
CFU-Mk 
TGF-P* TGF-PR CFU-GM Inhibition on proliferation and 
differentiation of CFU-GM 
GM-CSF GM-CSFRBFU-E Stimulate proliferation and 
differentiation of BFU-E 
IL-3 IL-3R BFU-E Stimulate proliferation and 
Erythropoietic differentiation of BFU-E 
factors IL-11 IL-llR BFU-E Stimulate proliferation and 
differentiation of BFU-E 
SCF KIT BFU-E Stimulate proliferation and 
differentiation of BFU-E 
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IL-3 IL-3R Pre-B cells Stimulate proliferation and 
differentiation of Pre-B cells 
Lymphopoietic IL-7 IL-7R Pre-B cells, Stimulate proliferation and 
factors cortical differentiation of Pre-B cells, 
thymocyte, cortical thymocyte, T-cell 
T-cell 
* These stromal-derived factors were also shown to be essential in hepatocytes proliferation after liver 
injury as discussed in section 1.1 and summarized in table 1. 
G-CSF, granulocyte colony-stimulating factor; G-CSFR, granulocyte colony-stimulating factor 
receptor; M-CSF, macrophage colony-stimulating factor; CSFR, colony-stimulating factor receptor; 
GM-CSF, granulocyte-macrophage colony-stimulating factor; GM-CSFR, granulocyte-macrophage 
colony-stimulating factor receptor; HGF, hepatocyte growth factor; IL, interleukin; ILR, interleukin 
receptor; SCF, stem cell factor; TGF-p, transforming growth factor-p; TGF-PR, transforming growth 
factor-p receptor 
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1.2.4 Endocrine in hepatocytes proliferation 
When the parabiotic circulation of two rats are connected surgically, PHx in one unit 
can trigger hepatocytes proliferation in both units (Moolten and Bucher, 1967; Fisher 
et al , 1971). In addition, after PHx, the first portion of hepatocytes in hepatic 
lobules undergo proliferation was periportal zone (Rabes et al., 1976) prolonging to 
the pericentral zone. Periportal zone surrounds portal triads which includes portal 
vein, hepatic artery and bile ductule. The inactive, hepatic biomatrix-bound HGF is 
retained primarily at the periportal zone (Liu et al , 1994). Hepatic uptake of EGF in 
rat after an intravenous injection is also retained primarily at the periportal biomatrix 
(St Hilaire et al , 1983). Hepatocytes contain significant intracellular concentrations 
of TGF-P 12 hr after PHx. The increase of internalized TGF-P concentration is 
starting from periportal zone prolonging to the pericentral zone (Jirtle et a l , 1991). 
The hepatic oval cells also originate from the cells present in the canals of Herring, 
the smallest intralobular biliary ducts or small marginal interlobular biliary ducts 
located at the periportal zone and from blast-like cells located next to the bile ducts 
(Novikoff et al., 1996). These evidences suggested that blood circulation delivered 
mitogen(s), which could trigger the liver regeneration after PHx starting from the 
area closest to hepatic artery. The highly localized biomatrix-bound pro-HGF stock, 
EGF uptaken capacity of biomatrix and the removal of TGF-P inhibition from the 
extracellular environment of hepatocytes reinforce the importance of periportal zone, 
the hepatocytes proliferation ready area in response to blood delivering mitogens. 
However, the function of hepatic oval cells on regulating hepatocytes proliferation 
need to be clarified. In conclusion, it is reasonable to postulate that bone marrow 
stromal cells may regulate the hepatocytes proliferation through its growth factors 
secretion by an endocrine mechansim. 
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1.3 Objective of this study 
The objective of this study was to demonstrate that the human bone marrow stromal 
cells have mitogenic activity on hepatocytes by (i) selection of human hepatic cell 
line for the detection of mitogenic activity; (ii) detection of mitogenic activity of 
human bone marrow stromal cells on the selected cell line, SK-Hep-1 cells; (Hi) 
characterization of hepatocyte mitogenic activity of bone marrow stromal cellular 
extract; and (iv) performing a preliminary test on the difference between bone 
marrow stromal cellular extract and other growth factors. 
(i) "Selection of human hepatic cell line for the detection of mitogenic activity" was 
determined by the ability of human hepatic cell lines, Hep 3B, Hep G2, C3A, SK-
Hep-1 and Chang cells to be enriched at GO-Gl phases of the cell cycle by serum 
deprivation (Campisi et al , 1984). Cell cycle distribution changes of serum deprived 
hepatic cells with or without mitogenic stimulation were also determined to ensure 
that blocking cells from cycling was not result in death of the cells. 
The DNA synthesis of human hepatocarcinoma, Hep 3B, Hep G2, C3A, SK-Hep-1 
and Chang cells can be triggered by hepatocyte mitogens, HGF, EGF and TGF-a 
(Lee et a l , 1998; Guren et al., 1999; Tamura and Daikuhara, 2000). Hep 3B cells 
have been shown to be an experimental model for investigation of plasma protein 
biosynthesis of liver (Knowles et al” 1980). Hep G2 and SK-Hep-1 cells have been 
shown to be a well-characterized model for studying liver detoxification including 
cytochrome P450 activity (Gabelova et al , 2000). C3A cells are clonal derivative of 
Hep G2 cells that are selected for strong contact inhibition of growth and high 
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albumin production. Chang cells are derived from normal liver tissue. Selection was 
made from these hepatic cell lines. 
Serum deprivation for obtaining GO-Gl phases has been used in many cell cycle-
related studies, including analysis of the cell cycle-dependent reversible tyrosine 
phosphorylation of cdc2 (Morla et al , 1989) and regulation of cyclin A (Carbonaro-
Hall et al., 1993). Cells synchronized at the Gl-S boundary by chemical inhibitor, 
thymidine, mimosine, or aphidicolin had 4 fold higher levels of cyclins E and B1 
suggesting that chemical treatment has been linked to the possible disruption of 
normal cell cycle regulatory process (Schimke et al , 1991; Gong et a l , 1995). Thus 
serum deprivation was used for obtaining enrichment of GO-Gl phases in this 
project. 
(ii) "Detection of mitogenic activity of human bone marrow stromal cells on the 
selected cell line, SK-Hep-1 cells" was defined by cell cycle distribution changes of 
partially growth arrested SK-Hep-1 cells before and after primary bone marrow 
stromal cellular extract incubation. The primary stromal cells were obtained from 
fresh human bone marrow biopsy sample of leukemia patient. 
All of the stromal cell lines being reported have different predominant cytokines 
production indicating that stromal cell lines are lineage restricted in its hematopoietic 
support capacity (Greenberger, 1991). It is well established that pluripotent stem 
cells and other precursors in different hematopoietic lineages including pro-B-cells, 
cortical thymocyte, CFU-GM, CFU-G, CFU-M, CFU-E and CFU-Mk can persist for 
several weeks in LTBMC as cultivating with primary stromal cells(Muller-Sieburg 
and Deryugina, 1995). Thus primary stromal culture was used in order to exclude 
the predominant cytokines production of cell lines-derived cytokines. 
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The primary stromal cells were obtained from human bone marrow according to two 
well-established culture systems for LTBMC (Dexter et al.，1977; Whitlock and 
Witte, 1982). Briefly, stromal cells were cultured in medium supplemented with 
relatively high concentration of fetal calf serum, usually 15 - 25 %. Thus co-
culturing of partially growth arrested SK-Hep-1 cells and stromal cells was unable to 
determine the mitogenic activity of stromal cells because the constitutively 
production of cytokines from stromal cells required under cultivating with high 
concentration of serum, which was already a strong mitogens for serum deprived SK-
Hep-1 cells. The alternative, stromal cellular extract was used for the detection of 
mitogenic activity of stromal cells on SK-Hep-1 cells. The preparation of stromal 
cellular extract was prepared as described by Ho and his colleagues (Ho et al., 1998). 
Leukemia defines as fatal diseases of the reticuloendothelial system involving 
uncontrolled proliferation of leukocytes. The primary stromal cells were obtained 
from fresh human bone marrow biopsy sample of leukemia patient because of the 
availability of bone marrow sample. The bone marrow stromal cells obtained were 
presumably normal (Ho et al , 1998). 
(iii) "Characterization of hepatocyte mitogenic activity of bone marrow stromal 
cellular extract" was defined by dialysis, temperature treatment, and proteolysis. 
(iv) "Performing a preliminary test on the difference between bone marrow stromal 
cellular extract and other growth factors" was determined by the comparison of 
mitogenic response and early intracellular signaling of SK-Hep-1 cells in response to 
bone marrow stromal cellular extract and other growth factors. These experiments 
provided a basis evidence for detail experimental study. 
15 ‘ 
Chapter 2 Materials and Methods 
2.1 Cell cultures 
Human hepatocytes, Hep 3B and SK-Hep-1 (American Type Culture Collection, 
Manassas, VA，USA) were routinely maintained in Dulbecco's modified Eagle's 
medium (DMEM, GIBCO-BRL, Life Technologies, Gaithersberg, MD, USA) 
supplemented with 10 % fetal bovine serum (FBS, GIBCO), while Hep G2, C3A and 
Chang cells (ATCC) were routinely maintained in Minimum essential medium 
(MEM, GIBCO) supplemented with 10 % FBS. Primary human bone marrow stromal 
cells were routinely maintained in DMEM supplemented with 15 % FBS. All cell 
cultures were incubated in humidified air with 5 % CO2 at 37 by CO2 water 
jacketed incubator (Forma Scientific Inc., Marietta, OH, USA). Cell count was 
determined via Coulter Particle Count and Size Analyser (Coulter electronics Ltd., 
Northwell Drive, Luton, England). Cell doubling time was calculated as N = No x 2 
where N equals to final cell count, No equals to seeding cell count, t equals to the 
culturing time and td equals to the cell doubling time. All cells were frozen with 67% 
culture medium, 25% FBS and 8% dimethyl sulphoxide (DMSO, Sigma, St. Louis, 
MO, USA). 
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2.2 Selection of human hepatic cell line for the detection of 
mitogenic activity 
2.2.1 Enrichment of human hepatic cell lines, Hep 3B, Hep G2, C3A, SK-Hep-1 
and Chang cells at GO-Gl phases by serum deprivation 
Enrichment of hepatic cell lines, Hep 3B, Hep G2, C3A, SK-Hep-1 and Chang cells at 
GO-Gl phases were obtained by serum deprivation. Hep 3B and SK-Hep-1 cells were 
plated at 3,200 cells/cm^ (0.015 x 10^ cells/ml x 6 ml in 60 mm dish) in DMEM 
supplemented with 10 % FBS for 24 hr, while Hep G2, C3A and Chang cells were 
plated at 3,200 cells/cm^ in MEM supplemented with 10 % FBS for 24 hr. Then the 
cells were washed once with culture medium followed by incubating in culture 
medium supplemented with 0.5，0.3，and 0.1 % FBS. Cells were starved for another 
72 hr before experiments. 
2.2.2 Incubation of serum deprived Hep 3B, Hep G2, C3A, SK-Hep-1 and 
Chang cells with mitogenic stimuli 
The serum deprived hepatic cell lines, Hep 3B，Hep G2, C3A, SK-Hep-1 and Chang 
cells were incubated with 10 % FBS for 21hr. 
2.2.3 Cell cycle analysis by flow cytometry using propidium iodide staining 
Cell cycle distribution of serum deprived Hep 3B, Hep G2, C3A, SK-Hep-1 and 
Chang cells with or without mitogenic stimulation were analyzed by propidium iodide 
staining. Cells were dislodged by trypsinization. Then, the cells were washed once 
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with 1 ml cold phosphate-buffered saline (PBS, 137 mM sodium chloride, 2.7 mM 
potassium chloride, 4.3 mM sodium phosphate, dibasic and 1.4 mM potassium 
phosphare, monobasic, pH 7.4) before fixed with 1 ml cold 95 % ethanol in PBS for 
15 minutes. Cells were incubated with 0.1 % ribonuclease A (RNase A, Sigma) at 
37 for 20 min in 500 \x\ PBS after filtering against 35 |Lim stainer cap (Falcon, 
Becton Dickinson, San Jose, CA, USA). Cells were stained with 50 |ng/ml propidium 
iodide solution on ice in dark for 30 min. DNA content of 10,000 events (cells) were 
gated per sample by flow cytometry (Becton Dickinson) with excitation wavelength 
488 nm and emission wavelength 575 nm. Cell cycle distribution was analyzed by 
ModFit LT program (Verity Software House Inc., Topsham, ME, USA). 
2.3 Detection of mitogenic activity of human bone marrow stromal 
cells on the selected cell line, SK-Hep-1 cells 
2.3.1 Partially growth arrested human SK-Hep-1 cells 
The partially growth arrested SK-Hep-1 cells were obtained by the method of serum 
deprivation. Cells were plated at 3,200 cells/cm^ (0.015 x 10^ cells/ml x 6 ml in 60 
mm dish) in DMEM supplemented with 10 % FBS for 24 hr. Then the cells were 
washed once with DMEM followed by incubating in DMEM supplemented with 0.1 
o/o FBS. Cells were incubated for another 72 hr before experiments. 
Limited passages of SK-Hep-1 cells between 8 and 11 were used for experiments in 
order to minimize clones deviation upon passing. And the cell doubling time should 
be around 1.3 day before experiments. 
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2.3.2 Human bone marrow stromal cells 
Primary human bone marrow stromal cells were obtained from fresh human bone 
marrow biopsy sample of leukemia patient. Sample was incubated in RPMI medium 
1640 (GIBCO) supplemented with 10 % FBS and 100 units/ml penicillin and 100 
mg/ml streptomycin (Sigma) for 24 hr. Then suspended hematopoietic cells from the 
attached stromal cells were washed with DMEM five times followed by growing the 
cells in DMEM supplemented with 15 % FBS. 
2.3.2.1 Bone marrow stromal cellular extract 
Bone marrow stromal cells were harvested by trypsinization. Each million cells were 
washed with 0.5 ml cold phosphate-buffered saline (PBS, 137 mM sodium chloride, 
2.7 mM potassium chloride, 4.3 mM sodium phosphate, dibasic and 1.4 mM 
potassium phosphate, monobasic, pH 7.4) five times. Five millions cells were 
resuspended in one ml of PBS. Cells were lysed with Ultrasonic Processor (Cole-
Parmer Instrument Co., Vernon Hills, IL, USA) with power 2, total process time 30 
sec, pulse on time 1 sec and pulse off time 1 sec on ice. Debris was spun down by 
ultracentrifuge (Beckman Instruments, Inc., Fullerton, CA，USA) using 70.1Ti rotor 
(Beckman) at 100,000 g at 4 for 1 hr. The supernatant, the total cellular extract, 
was further sterilized by filtration using a 0.22 |im filter (USA Scientific, Inc., Ocala, 
FL, USA). Cell lysate was aliquot and store at -80 before use. 
2.3.2.2 Total protein assay 
The total protein concentration of stromal cellular extract was determined by Bradford 
assay (Bradford, 1976) using bovine serum albumin (BSA, Sigma) as standard. 
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Protein samples were mixed with 5 X dye reagent concentrate (Bio-Rad Laboratories, 
Hercules, CA, USA) for 5 min at room temperature. The absorbance was measured at 
OD 595 nm at room temperature with a spectrophotometer (Beckman). The protein 
concentration was calculated from the standard curve. 
2.3.3 Incubation of SK-Hep-1 cells with bone marrow stromal cellular extracts 
For the time course experiment on DNA synthesis of SK-Hep-1 cells in response to 
FBS and bone marrow stromal cellular extract, partially growth arrested SK-Hep-1 
cells were incubated with 10 % FBS and 30 |Lig/ml stromal cellular extract of patient 1 
for 6，9，12，15, 18,21, 24 hr and 15，18，21，24，25，27, 30 hr, respectively. 
For the dose response experiment on DNA synthesis of SK-Hep-1 cells in response to 
bone marrow stromal cellular extracts, partially growth arrested SK-Hep-1 cells were 
incubated with 5, 10，20，30 and 40 |Lig/ml stromal cellular extracts originated from 
four different patients for 21 hr. 
Cell cycle distribution of stromal cellular extract treated SK-Hep-1 cells were 
analyzed as described in section 2.2.3 
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2.4 Characterization of hepatocyte mitogenic activity of bone 
marrow stromal cellular extract 
2.4.1 Dialysis 
The bone marrow stromal cellular extract of patient 1 was dialyzed against 2 L PBS 
with 3 changes of buffer at 4 V for 17 hr. The molecular weight cut-off (MWCO) of 
dialysis tubings using were 3.5 and 14 kDa (Spectrum Laboratories Inc., Rancho 
Dominguez, CA, USA). The tubing was first boiled in sodium bicarbonate / EDTA 
solution (1 mM EDTA and 2 % sodium bicarbonate) for 10 min followed by boiling 
in 0.1 M EDTA solution for another 10 min. Boiled tubing was rinsed extensively 
with PBS before use. The dialyzed extract of patient 1 was further sterilized by 
filtering against 0.22 jiim filter and measured the total protein content (section 2.3.2.2) 
before testing for hepatocyte mitogenic activity as described in section 2.2.3. The 
partially growth arrested SK-Hep-1 cells was incubated with 15 [ig/m\ dialyzed 
stromal cellular extract of patient 1 for 21 hr. 
2.4.2 Temperature treatment 
The bone marrow stromal cellular extract of patient 1 was subjected to a serial 
temperature treatment, at 22，37, 45, 65 and 100 in water bath for 30 min before 
testing for hepatocyte mitogenic activity as described in section 2.2.3. The partially 
growth arrested SK-Hep-1 cells was incubated with 30 |ag/ml temperature treated 
stromal cellular extract of patient 1 for 21 hr. 
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2.4.3 Proteolysis 
The bone marrow stromal cellular extract of patient 1 was separately digested with 
0.3 fig/ml trypsin (Roche Molecular Biochemical, Boehringer Mannheim, Sandhofer 
Strasse, Mannheim, Germany) and 0.3 |Lig/ml endoproteinase Lys-C (Roche) at 37 
for 30 min. Proteolysis was inhibited by 10 pg/ml N-Tosyl-L-lysine chloromethyl 
ketone (TLCK) (Roche) before testing for hepatocyte mitogenic activity as described 
in section 2.2.3. The partially growth arrested SK-Hep-1 cells was incubated with 30 
|Lig/ml digested stromal cellular extract of patient 1 for 21 hr. 
2.5 Performing a preliminary test on the difference between bone 
marrow stromal cellular extract and other growth factors 
2.5.1 Incubation of SK-Hep-1 ceils with bone marrow stromal cellular extract 
or other growth factors 
Partially growth arrested SK-Hep-1 cells were incubated with 30 |ig/ml bone marrow 
stromal cellular extracts of patient 1, 10 % FBS, human recombinant stimulatory 
growth factors, 30 ng/ml HGF, 2 |Lig/ml insulin, 1 ng/ml EGF and 1 ng/ml TGFa 
(Calbiochem — Novabiochem Corporation, La Jolla, CA, USA) and 40 |ig/ml cells 
lysate of itself, for 21 hr. Hepatocyte mitogenic activities were tested as described in 
section 2.2.3. The preparation of SK-Hep-1 cells lysate was as same as the 
preparation of stromal cellular extract described in section 2.3.2.1. 
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2.5.2 Metabolic labeling of SK-Hep-1 cells with [^^PJorthophosphate 
Partially growth arrested SK-Hep-1 cells were washed once with 3 ml warm labeling 
medium, phosphate free DMEM (GIBCO). Then incubate cells with ^^Pj, 0.1 mCi/ml, 
carrier free (Amersham Pharmacia Biotech UK Ltd., Little Chalfont, 
Buckinghamshire, England) for 3 hr in 2 ml labeling medium. 
2.5.3 Incubation of labeled SK-Hep-1 cells with bone marrow stromal cellular 
extract or other growth factors 
After 3 hr labeling, SK-Hep-1 cells were further incubated with 30 [ig/m\ bone 
marrow stromal cellular extracts of patient 1，10 % FBS, 30 ng/ml HGF, 2 ^g/ml 
insulin, 1 ng/ml EGF and 1 ng/ml TGFa for 15, 30，45 and 60 min. 
2.5.4 SK-Hep-1 cells lysate extraction 
The protein phosphorylation was stopped by washing twice with 20 mM cold Tris-
HCl buffer. SK-Hep-1 cells were lysed with 200 lysis solution (8 M urea, 4 % 
triton X-100, 40 mM trizma base and 20 mM DL-dithiothreitol) and further incubated 
on ice for 20 min. Debris was spun down by microcentrifuge (Eppendorf, 
Barkhausenweg, Hamburg, Germany) using FA 45-30-11 rotor (Eppendorf) at 10,000 
g at 4 oc for 10 min. About 0.035 x cells' lysate was mixed with 200 cold 
rehydration stock solution with IPG buffer (8 M urea, 2 % triton X-100, 0.5 % IPG 
buffer pH 3-10 linear, trace amount of bromophenol blue and 0.3 % DL-
dithiothreitol). Molecular weight and isoelectric point were determined by two-
dimensional SDS-PAGE standards (Bio-Rad) seperated on parallel processed gel. 
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2.5.5 Two-dimensional electrophoresis 
Two-dimensional electrophoresis was carried out as described by Gorg and her 
colleagues (Gorg et al , 1985; Gorg et al” 1988) using isoelectric focusing (lEF) in the 
first dimension and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) in the second dimension. 
2.5.5.1 First dimension isoelectric focusing 
Immobiline DryStrip gel, pH 3 - 10 linear, 11 cm (IPG Strip) (Pharmacia) was 
rehydrated with the sample mixture overnight at room temperature covered with IPG 
Cover Fluid (Pharmacia) in a reservoir slot of Immobiline DryStrip Reswelling Tray 
(Pharmacia). 
Proteins on IPG strip were focused by Multiphor II unit (Pharmacia) with Immobiline 
DryStrip Kit (Pharmacia). A total 12,000 V-hr was applied with several gradients 
increased in voltage up to 3,500 V according to the following conditions: 
PhaseVol t age (V) Current(mA)~~Power(W)Volt-hr(Vh) Time(h:min) 
1 m 2 5 i m 
2 3,500 2 5 2,900 1:30 
3 3,500 2 5 9,100 2:35 
Total: 12,000 
* Set the temperature on Multi Temp III Thermostatic Circulator (Pharmacia) to 20"C. 
Program power supply (Pharmacia) in gradient mode. 
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2.5.5.2 Second dimension sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis 
Each focused IPG strip was immediately equilibrated with 10 ml SDS equilibration 
buffer with DTT (0.1 M tris-HCl, 6 M urea, 30 % glycerol, 1 % SDS and 0.5 % DL-
dithiothreitol) for 10 min under gentle agitation. The buffer was replaced with 10 ml 
SDS equilibration buffer with iodoacetamide (0.1 M tris-HCl, 6 M urea, 30 % 
glycerol, 1 % SDS, trace amount of bromophenol blue and 4.5 % iodoacetamide) for 
another 10 min under gentle agitation. 
Focused proteins were resolved on precast gradient gel, ExcelGel SDS, 5 % stacking 
gel, 8 - 1 8 % separating gel (Pharmacia) using Multiphor II unit. A total 1,050 V-hr 
was applied with several stepwise increased in current up to 50 mA per gel according 
to the following conditions: 
PhaseVol t age (V) Current(mA)* Power(W)* Volt-hr(Vh) Time(h:min) 
2 600 50 30 50 0:05 
3 600 50 30 700 1:10 
Total: 1,050 n45 
* Set the temperature to 15 C. Program power supply in step mode. Multiple the 
current and power by 2 for dual gels running simultaneously. 
2.5.6 Amplification of radiolabeled signal by ENTRANCE 
The resolving gel was fixed with fixer solution (10 % acetic acid and 40 % ethanol) 
for 20 min under gentle agitation. After fixation, impregnate the fixed gel in a 
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fluorescent intermediate, ENTRANCE (NENTm Life Science Products, Boston, MA, 
USA) for 1 hr under gentle agitation. Following impregnation, precipitate the 
fluorescent material inside the gel with Milli Q water (Millipore Corporation, 
Bedford, MA, USA) for 10 min under gentle agitation. 
2.5.7 Visualization of autoradiography 
The impregnated gel was dried at 70 ^C under vacuum for 30 min by Gel Dryer (Bio-
Rad) and exposed to BioMax MR autoradiography film (Eastman Kodak Company, 
Rochester, NY, USA) at -80 overnight. 
2.5.8 Visualization by silver staining 
The 2-D SDS-PAGE standards were visualized by using PlusOne Silver Staining Kit, 
Protein (Pharmacia) with Hoefer Automated Gel Stainer (Pharmacia). Briefly, the 
resolving gel was fixed in fixer solution for 30 min. The proteins were then rendered 
more reactive towards silver in sensitizing solution (6.8 % sodium acetate, 0.2 % 
sodium thiosulfate, 30 % ethanol and 0.125 % glutardialdehyde) for 30 min. After 
Milli Q washing, the gel was impregnated with silver solution (0.25 % silver nitrate 
and 0.0148 % formaldehyde) for 20 min. The silver ion was reduced to metallic silver 
in developing solution (2.5 % sodium carbonate and 0.0074 % formaldehyde) for 4 to 
10 min. When the protein spots developed, the gel was incubated with stop solution 
(1.46 % EDTA) for 10 min preventing from further reduction of silver ion. Finally, 
the gel was preserved with the 8.7 % glycerol solution. Stained gel was dried as 
described in section 2.5.7. 
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Chapter 3 Results 
3.1 Selection of human hepatic cell line for the detection of 
mitogenic activity 
3.1.1 Enrichment of human hepatic cell lines, Hep 3B, Hep G2, C3A, SK-Hep-
1 and Chang cells at GO-Gl phases by serum deprivation 
The selection of human hepatic cell line for the detection of mitogenic activity was 
determined by the ability of hepatic cell lines, Hep 3B, Hep G2，C3A, SK-Hep-1 and 
Chang cells to be enriched at GO-Gl phases. Only SK-Hep-1 and Chang cells can be 
synchronized at GO-Gl phases by serum deprivation (Figure 1). There were about 
17 o/o and 14 % rise in GO-Gl phases of the total cell population in SK-Hep-1 and 
Chang cells as starving with 0.1 % FBS, respectively. 
/ 
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Figure 1. Enrichment of human hepatic cell lines at GO-Gl phases by serum 
deprivation. Hep 3B, Hep G2, C3A, SK-Hep-1 and Chang cells were seeded in 
culture medium supplemented with 10 % FBS for 24 hr. Then the cells were washed 
once with culture medium followed by incubating in culture medium supplemented 
with 0.5, 0.3, and 0.1 % FBS. Cell cycle analyisis was performed after serum 
deprivation for 72 hr. "Percentage rise in GO-Gl phases of the total population" was 
determined by the percentage of cells in GO-Gl phases with serum deprivation 
treatment minus the percentage of control cells in GO-Gl phases without serum 
deprivation treatment. Data were mean of two experiments in duplicates 土 S.D. 
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3.1.2 DNA synthesis of hepatic cell lines in response to 10 % FBS after serum 
deprivation 
The DNA synthesis of hepatic cell lines, Hep 3B, Hep G2, C3A, SK-Hep-1 and 
Chang cells in response to 10 % FBS after previously serum deprivation were 
determined by cell cycle analysis. Only growth arrested SK-Hep-1 and Chang cells 
demonstrated the ability to response to mitogenic stimulation after serum deprivation 
(Figure 2). There were about 31 % and 19 % rise in S/G2-M phases of the total cell 
population in SK-Hep-1 and Chang cells after 10 % FBS stimulation in cells starving 
with 0.1 % FBS, respectively. 
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Figure 2. DNA synthesis of hepatic cell lines in response to 10 % FBS after 
serum deprivation. After serum deprivation for 72 hr with 0.5, 0.3，and 0.1 % FBS, 
Hep 3B，Hep G2, C3A, SK-Hep-1 and Chang cells, cells were incubated with 10 % 
FBS mitogenic stimulation for 21hr. Cell cycle analysis was performed after 21 hr. 
"Percentage rise in S/G2-M phases of the total population" was determined by the 
percentage of cells in S/G2-M phases with 10 % FBS stimulation minus the 
percentage of control cells in S/G2-M phases without stimulation. Data were mean 
of two experiments in duplicates 土 S.D. 
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3.2 Detection of mitogenic activity of human bone marrow 
stromal cells on the selected cell line, SK-Hep-1 cells 
3.2.1 Cell cycle distribution of partially growth arrested SK-Hep-1 cells in 
response to mitogens 
The mitogenic effect of human bone marrow stromal cellular extract on partially 
growth arrested SK-Hep-1 cells was determined by cell cycle analysis. The 
percentage of SK-Hep-1 cells in S/G2-M phases under the stimulation of FBS 
(Figure 3B) and stromal cellular extract of patient 1 (Figure 3C) were 30 % (S.D. = 土 
0.2; n = 5) and 17 % (S.D. = 土 0.7; n = 5) increased, respectively as compared to the 
untreated control (Figure 3A). The mitogenic activity was defined by cell cycle 
distribution changes of SK-Hep-1 cells before and after mitogens incubation 
throughout the experiment. 
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Figure 3. Cell cycle distribution of partially growth arrested SK-Hep-1 cells in 
response to mitogens. The representative diagrams of cell cycle distribution of 
partially growth arrested SK-Hep-1 cells without treatment (A), cells incubated with 
10 o/o FBS for 21 hr (B) and cell incubated with 30 |ig/ml bone marrow stromal 
cellular extract of patient 1 for 21 hr (C) were shown. The fluorescence intensity of 
cell stained with propidium iodide was measured by the flow cytometry. Those SK-
Hep-1 cells that had an unreplicated complement of DNA, 2N were in GO-Gl phases. 
Those SK-Hep-1 cells that had a fully replicated complement of DNA, 4N were in 
G2-M phases. Those had an intermediate amount of DNA were in S phases. 
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3.2.2 Time course on DNA synthesis of partially growth arrested SK-Hep-1 
cells in response to FBS and bone marrow stromal cellular extract 
The optimum mitogenic response of partially growth arrested SK-Hep-1 cells was 
determined through a time course experiment on DNA synthesis of SK-Hep-1 cells 
in response to FBS and stromal cellular extract of patient 1. The mitogenic activity 
was detectable by 12 hr and appeared to be maximal at about 21 hr (Figure 4). 
Similar result was found in cells under stimulation with stromal cellular extract of 
patient 1. Thus, the peak of mitogenic activity in partially quiescent SK-Hep-1 cells 
occurred at about 21 hr after mitogen inoculation and this inoculation time was used 
throughout the experiment. 
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Figure 4. Time course on DNA synthesis of partially growth arrested SK-Hep-1 
cells in response to FBS and bone marrow stromal cellular extract. Partially growth 
arrested SK-Hep-1 cells were incubated with 10 % FBS and 30 }ig/ml stromal 
cellular extract of patient 1 for 6，9，12, 15, 18，21, 24 hr and 15, 18，21, 24, 25，27, 
30 hr, respectively. The mitogenic activity of 10 % FBS (1，-•-) and 30 ^ig/ml bone 
marrow stromal cellular extract of patient 1 (2, - • - ) on DNA synthesis of SK-Hep-1 
cells from 6 to 30 hr were shown. "Percentage rise in S/G2-M phases of the total 
population" was determined by the percentage of cells in S/G2-M phases with 
mitogenic stimulation minus the percentage of control cells in S/G2-M phases 
without stimulation. Data were the mean of two experiments in duplicates 土 S.D. 
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3.2.3 Dose response on DNA synthesis of partially growth arrested SK-Hep-1 
cells in response to bone marrow stromal cellular extracts 
Mitogenic activity of human bone marrow stromal cellular extract on partially 
growth arrested SK-Hep-1 cells was determined through a dose response experiment 
on DNA synthesis in response to stromal cellular extracts originated from four 
different patients. Dosage curve on DNA synthesis of SK-Hep-1 cells was observed 
upon stimulation with four different bone marrow stromal cellular extracts. The 
maximum percentage of cells increase in S/G2-M phases was 19 % under 30 fig/ml 
stromal cellular extract stimulation. 
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Dose response on DNA synthesis of 
partially growth arrested SK-Hep-1 
cells in response to bone marrow 
stromal cellular extracts 
patient 
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Protein concentration (i^g/ml) 
Figure 5. Dose response on DNA synthesis of partially growth arrested SK-Hep-1 
cells in response to bone marrow stromal cellular extracts. The graph showed the 
mitogenic activities of 5, 10，20, 30 and 40 fig/ml stromal cellular extracts originated 
from four different patients (1, -•-; 2，-A-; 3 ， 4 , - • - ) on partially growth arrested 
SK-Hep-1 cells incubating for 21 hr. "Percentage rise in S/G2-M phases of the total 
population" was determined by the percentage of cells in S/G2-M phases with 
mitogenic stimulation minus the percentage of control cells in S/G2-M phases 
without mitogenic stimulation. Data were the mean of two experiments in duplicates 
土 S.D. 
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3.3 Characterization of hepatocyte mitogenic activity of bone 
marrow stromal cellular extract 
The physical properties of hepatocyte mitogenic activity of bone marrow stromal 
cellular extract including the approximate size, thermostability and resistance to 
proteinase digestion were characterized by dialysis, temperature treatment and 
proteolysis, respectively. The mitogenic activity of stromal cellular extract of patient 
1 was about the same before and after dialyzed against 3.5 and 14 kDa MWCO 
dialysis tubing (Figure 6A). The mitogenic activity of stromal cellular extract of 
patient 1 lost progressively with 63 % reduction in mitogenic activity after 65®C heat 
treatment (Figure 6B). The mitogenic activity of stromal cellular extract of patient 1 
lost after digested with trypsin or endoproteinase Lys-C with 88 % reduction and 76 
% reduction in mitogenic activity after 37 digestion for 30 min (Figure 6C). 
These results suggested that most of the hepatic mitogenic effect of stromal cellular 
extract from patient 1 was heat labile proteins with size larger than 14 kDa. 
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Figure 6. Characterization of hepatocyte mitogenic activity of bone marrow stromal 
cellular extract. The data showed the mitogenic activities of stromal cellular extract 
of patient 1 on partially growth arrested SK-Hep-1 cells pretreated with 3.5 and 14 
kDa MWCO dialysis at 4 overnight (A); 22，37，45, 65 and 100 temperature 
treatment for 30 min (B); and 0.3 |ag/ml trypsin and 0.3 |ig/ml endoproteinase Lys-C 
proteolysis at 37°C for 30 min (C). "Percentage rise in S/G2-M phases of the total 
population" was determined by the percentage of cells in S/G2-M phases with 
mitogenic stimulation minus the percentage of control cells in S/G2-M phases 
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3.4 Performing a preliminary test on the difference between bone 
marrow stromal cellular extract and other growth factors 
3.4.1 Mitogenic response of SK-Hep-1 cells in response to bone marrow 
stromal cellular extract and other growth factors 
The mitogenic response of partially growth arrested SK-Hep-1 cells in response to 
stromal cellular extract of patient 1 and other known hepatocyte stimulatory growth 
factor, namely HGF, EGF, TGF-a and insulin were determined. The percentages of 
cells increase in S/G2-M phases were 12，7，5，10 and 18 % in 30 ng/ml HGF, 1 
ng/ml EGF, 1 ng/ml TGF-a, 2 )ag/ml insulin and 30 )ig/ml stromal cellular extract of 
patient 1，respectively. 
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Mitogenic response of SK-Hep-1 cells in 
response to bone marrow stromal 
cellular extract and other growth factors 
40-1 � E石 
30- ^ 
O) CD Q. 
I - § . 8 . 20-
, J l l i i i ^ i i 
10% 40|ig/ml 30ng/ml 1 ng/ml 1ng/ml 2^ig/ml 30 ng/ml 
FBS SK-Hep-1 HGF EGF TGF-a insulin stromal 
cells cellular 
lysate extract of 
patient 1 
Stromal cellular extract of patient 1 and 
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Figure 7. Mitogenic response of SK-Hep-1 cells in response to bone marrow stromal 
cellular extract and other growth factors. The chart showed the mitogenic activities 
of 10 o/o FBS, 40 |ig/ml SK-Hep-1 cells lysate, 30 ng/ml HGF, 1 ng/ml EGF, 1 ng/ml 
TGF-a, 2|ig/ml insulin and 30 |Lig/ml stromal cellular extract of patient 1 on partially 
growth arrested SK-Hep-1 cells after incubation for 21 hr. "Percentage rise in S/G2-
M phases of the total population" was determined by the percentage of cells in S/G2-
M phases with mitogenic stimulation minus the percentage of control cells in S/G2-
M phases without stimulation. Data were the mean of two experiments in duplicates 
土 S.D. 
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3.4.2 Early intracellular signaling of SK-Hep-1 cells in response to bone 
marrow stromal cellular extract and other growth factors 
The early intracellular signaling of SK-Hep-1 cells in response to bone marrow 
stromal cellular extract of patient 1 was compared with other known hepatocyte 
stimulatory growth factor, namely HGF, EGF, TGF-a and insulin. These results 
showed that the general phorphorylation pattern of partially growth arrested SK-
Hep-1 cells in response to either stromal cellular extract of patient 1 or stimulatory 
growth factors were as same as the untreated control for 15, 30, 45 and 60 min 
except under stimulation with 30 |ag/ml stromal cellular extract of patient 1 for 30 
min. A unique phosphoprotein spot was detected with molecular weight at 21.5 kDa 
and pi at 5.7 (Figure 6B). 
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Figure 8. Early intracellular signaling of SK-Hep-1 cells in response to bone 
marrow stromal cellular extract and other growth factors. These autoradiographs 
showed the general phorphorylation pattern of growth arrested SK-Hep-1 cells in 
response to stromal cellular extract of patient 1 and other growth factors stimulation. 
The general phosphorylation pattern of growth arrested SK-Hep-1 cells without 
treatment (A), cells incubated with 30 |Lig/ml stromal cellular extract of patient 1 for 
30 min (B), cells incubated with 10 % FBS for 30 min (C), cells incubated with 30 
ng/ml HGF for 30 min (D), cells incubated with 2 jig/ml insulin for 30 min (E), cells 
incubated with 1 ng/ml EGF for 30 min (F) and cells incubated with 1 ng/ml TGFa 



































































































































































































































Chapter 4 Discussion 
4.1 Selection of human hepatic cell line for the detection of 
mitogenic activity 
‘ Among hepatic cell lines, Hep 3B, Hep G2, C3A, SK-Hep-1 and Chang cells, it was 
demonstrated that SK-Hep-1 and Chang cells were enriched at GO-Gl phases after 
serum deprivation. And these growth arrested hepatic cells were able to continue 
through S/G2-M phases of the cell cycle upon 10 % FBS stimulation without death 
of the cells. This result suggested that both SK-Hep-1 and Chang cells can be 
growth arrested. Since SK-Hep-1 cells showed a higher percentage changes, about 
one-third higher upon FBS stimulation. Thus SK-Hep-1 cells were used throughout 
the experiment in order to maximize the sensitivity for detection of mitogenic 
activity. And the concentration of FBS being used to deprive cells was 0.1 % for 72 
hr. One of the limitation of using SK-Hep-1 cells was that the onwards data obtained 
might only unique to SK-Hep-1 cells or in vitro condition. 
I 
Serum withdrawal requires extensive optimization of both amount of serum 
withdrawn and the length of withdrawal. The concentration of 0.5 % - 0.1 % FBS 
covered the commonly used percentage of FBS for serum deprivation (Campisi et a l , 
1984). Although the increase in length of withdrawal might increase the percentage 
of Hep 3B, Hep G2, C3A cells synchronization at GO-Gl phases, the death of the 
cells will increase at the same time. Serum withdrawn for 72 hr was the commonly 
used time in the balance between the percentage of cells being synchronized and the 
number of death of cells (Campisi et al., 1984). 
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4.2 Mitogenic activity of human bone marrow stromal cells on the 
selected cell line, SK-Hep-1 cells 
In this study, it was demonstrated that a dosage dependent hepatocyte mitogenic 
activity of human bone marrow stromal cellular extracts originated from four 
different patients. This result suggested that human bone marrow stromal cells had 
specific hepatocyte mitogenic activity. The finding was in agreement with the report 
of Michalopoulos and DeFrances who reviewed the stimulating effect of stromal-
derived HGF on DNA synthesis of hepatocytes and the essential role of stromal-
derived IL-6 in early signaling pathway of hepatocyte proliferation (Michalopoulos 
and DeFrances, 1997). Thus, bone marrow stromal-derived cytokines, HGF and IL-6 
were potentially responsible for the stimulating effect on DNA synthesis of SK-Hep-
1 cells in this in vitro experiment. 
Liver is the principal hematopoietic organ in the human fetus from the through the 
22nd gestational weeks. Different hematopoietic lineages including myelopoietic, 
erythropoietic and lymphopoietic lineages proliferate and differentiate in the fetal 
liver from stem cells that migrate from the yolk sac (Timens and Kamps, 1997). 
Fetal hepatocytes extracellular matrix contains cytokines necessary for growth and 
development of hematopoietic cells in addition to itself. Those bone marrow 
stromal-derived cytokines involved in hepatocytes proliferation namely HGF, IL-6 
and TGF-p are also necessary in the myelopoiesis particularly in the CFU-GM 
lineage (Bot et al., 1989; Cashman et al , 1990; Kmiecik et al., 1992; Mizuno et al., 
1993; Galimi et al , 1994; Nishino et a l , 1995; Liu et a l , 1997; Takai et a l , 1997). 
CD 15 is a distinctive cell surface marker representing the colony formation from 
CFU-GM. Interestingly, in gestational week of fetal liver, the myelopoietic 
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CD 15 positive cells were localized mainly in periportal zone (Timens and Kamps, 
1997), the first portion of hepatocytes in hepatic lobules undergoing proliferation 
after PHx. The reason of such topographic distribution of myelopoietic cells remains 
unknown. In addition to the evidence that hepatocytes can arise from cell 
populations originating in bone marrow (Petersen et al., 1999), those potent bone 
marrow stromal-derived cytokines involved specifically in CFU-GM lineage 
development, namely G-CSF, GM-CSF and M-CSF (Nicola, 1987) may also be 
responsible for the stimulating effect on DNA synthesis of SK-Hep-1 cells in this in 
vitro experiment. 
4.3 Characterization of hepatocyte mitogenic activity of bone 
marrow stromal cellular extract 
Most of the stimulating effect of bone marrow stromal cellular extract of patient 1 on 
DNA synthesis of SK-Hep-1 cells lost after proteolysis and heat treatment suggested 
that the major stromal-derived hepatocyte mitogens were heat labile proteins. And 
the stimulating effect of bone marrow stromal cellular extract of patient 1 on DNA 
synthesis of SK-Hep-1 cells was maintained after dialysis indicated that the stromal-
derived hepatocyte mitogens were not a small molecular. These findings were in 
agreement with the physical properties of all above potential stromal-derived 
i 
hepatocyte cytokines being suggested. As all HGF, IL-6, G-CSF, GM-CSF and M-
CSF are heat labile proteins with molecular weight, 85, 25, 25, 23 and 70 kDa, 
respectively. 
Interestingly, some of the stimulating effect of bone marrow stromal cellular extract 
of patient 1 on DNA synthesis of SK-Hep-1 cells can not be eliminated after 
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proteolysis and heat treatment. This might be due to the present of non-protein 
nature mitogens or heat - stable proteins that resisted towards digestion with trypsin 
and endoproteinase Lys-C in the stromal cellular extract. Such observation had also 
been reported in human placental extract (Liu et a l , 1998) that human placental 
extract contains a heat-stable fraction, which can stimulate the growth of 
hepatocytes. 
4.4 Performing a preliminary test on the difference between bone 
marrow stromal cellular extract and other growth factors 
The infusion of HGF, EGF or TGF-a in normal rat directly through the portal vein 
could only have a little effect on hepatic DNA synthesis. It indicated that either 
multiple cytokines or an unknown cytokine was required for the initiation of 
hepatocytes proliferation after PHx (Webber et al., 1994). In this study, given 
together, no data can support whether the hepatic mitogenic activity of stromal cells 
was triggered by a known cytokine, an unknown cytokine or multiple stromal-
derived cytokines. The effect of stromal cellular extract on early intracellular 
signaling of SK-Hep-1 cells was performed with a parallel control on its DNA 
synthesis to examine the potential of difference between existing growth factors and 
stromal cellular extract. 
i 
A different phosphoprotein was detected in SK-Hep-1 cells at 30 min after 
inoculation with bone marrow stromal cellular extract. This phosphorylated protein 
was undetectable in SK-Hep-1 cells when inoculated with HGF, EGF, TGF-a, 
insulin or FBS alone. This showed that a different intracellular signaling messenger 
was being up regulated in SK-Hep-1 cells as the result of stromal cellular extract 
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treatment. The parallel experiment on increasing DNA synthesis of SK-Hep-1 cells 
was obtained. However, no data can further correlate this phosphorylated signal and 
the DNA synthesis, and whether this signal was a result from a known cytokine, an 
unknown cytokine or multiple stromal-derived cytokines. This experiment provided 
evidence leading to detail study. 
Interestingly, the mitogenic activity of FBS was always higher than the other 
mitogens or stromal cellular extracts throughout the study. This reflected the fact 
that FBS has tremendous amount of different cytokines. And the initiation of 
proliferation of cells always involve in many different cytokines. 
Hepatocytes exit from their normally quiescent state within 30 min after PHx as the 
immediate-early genes are rapidly induced (Taub, 1996). This expression is 
independent of protein synthesis and appears to result from mitogenic stimuli. Many 
of these immediate-early genes contain in their promotor region sequences reactive 
to the transcription factor, nuclear factor kappa B (NF-KB) and STAT3. Thus, 
activation of N F - K B and STAT3 are likely to be a major part of the intracellular 
signal transduction pathways leading to mitosis. The activation of N F - K B occurs 
within a minute after PHx (Cressman et a l , 1994) and the activation of STAT3 
occurs within 30 min peaking at 3 hr (Cressman et al” 1995). The different 
i 
intracellular signaling was detected in SK-Hep-1 cells by 30 min after inoculation 
with bone marrow stromal cellular extract suggesting this signaling messenger may 
involve in early intracellular signaling of SK-Hep-1 cells proliferation. 
Coupling between HGF and its transmembrane bound tyrosine kinase receptor, c-
Met activates the tyrosine Y1349 and Y1356 activity on its intercellular domain 
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resulting in mitogenic response in a wide variety of cells including hepatocytes 
(Ponzetto et al., 1994), while serine 985 in c-Met is the major phosphorylation site 
for protein kinase C or other Ca^^-dependent kinase(s) to down regulation this 
mitogenic response (Gandino et al , 1994). To detect this phosphorylated c-Met 
protein, purification from cells lysate through immunoprecipitation with monoclonal, 
c-Met/anti-c-Met conjugated with protein A-Sepharose should be carried out before 
gel loading. The unique intracellular signaling messenger detected in SK-Hep-1 
cells was resolved on 2D gel without antibody purification such as affinity 
chromatography or immunoprecipitation for a specific protein. One would expect 
that this strong phosphoprotein signal detected might involve in an amplifying 
cascade. 
4.5 Possible directions for future investigation 
Human bone marrow stromal cells secrete a lot of cytokines and some of these 
cytokines are already shown to be essential in triggering hepatocytes proliferation 
after liver regeneration. To examine the potential of difference between stromal-
derived factors and other growth factors, partially growth arrested SK-Hep-1 cells 
can be incubated with both stromal cellular extract and other growth factors or FBS 
simultaneously to determine whether there is a synergistic effect. If a synergistic 
< 
effect obtained, this indirect evidence can suggest that a difference might occur 
between stromal-derived factor and other cytokines on stimulation of hepatocytes 
proliferation. 
To screen for the stromal-derived factors that was responsible for the stimulation of 
hepatocytes, the direct method is to purify the factors by protein chromatography 
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such as ion-exchange chromatography and gel filtration. The mitogenic activity of 
different fractions obtained from separated stromal-derived extracts could be 
examined by partially growth arrested SK-Hep-1 cells. In order to avoid cell type-
specified result, primary hepatocytes culture should be used for investigation in 
addition to SK-Hep-1 cells. 
4.6 Conclusions 
(i) human bone marrow stromal cells had mitogenic activity on SK-Hep-1 cells; 
and 
(ii) these stromal-derived hepatocyte mitogens were mainly proteins in nature. 
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Chapter 5 Appendices 
5.1 Reagents and solutions 
Use Milli-Q water (Millipore Corporation, Bedford, MA, USA, ZMQS5VF0Y) for all the preparation 
of buffers. 
5.1.1 Selection of human hepatic cell line for the detection of mitogenic activity 
Equipment or reagent Supplier Code no. 
0.22 pm filter USA Scientific, Inc. USA F192 
35 [im stainer cap Falcon, Becton Dickinson 2235 
C3 A cells American Type Culture Collection CRL-10741 
Chang cells American Type Culture Collection CCL-13 
CO2 water jacketed incubator Forma Scientific Inc. 3111 
Coulter Particle Count and Size Analyser Coulter electronics Ltd. Z2 
Flow cytometry Becton Dickinson PASC Vantage 
Hep 3B cells American Type Culture Collection HB-8064 
Hep G2 cells American Type Culture Collection HB-8065 
Microcentrifuge Eppendorf 5417R 
Penicillin and streptomycin Sigma P0781 
SK-Hep-1 cells American Type Culture Collection HTB-52 
Cell fixation solution £ 500ml working concentration 
• Absolute ethanol (Riedel-de Haen, 32221, FW46.07) 475 ml 95 % (V/W) 
• I X PBS 25 ml 5%(V/V) 
Store at 4 
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Dulbecco's modified Eagle's medium Z 2 L working concentration 
• DMEM (GIBCO, 12800-017) 2 pack N/A 
• Sodium bicarbonate (NaHCOa) (Sigma, S2127, FW 106.0)7.4 g 0.37 % (W/V) 
Adjust pH to 7.50, 0.22 jam filter and store at 4 
Froze cells medium Z 10 ml working concentration 
• Culture medium (GIBCO) 6.7 ml 67 % (V/V) 
• Fetal bovine serum (FBS) (GIBCO, 26140-079) 2.5 ml 25 % (V/V) 
• Dimethyl sulphoxide (DMSO) (Sigma, D2650) 0.8 ml 8 % (V/V) 
Freshly prepared before use. 
Minimum essential medium Z 2 L working concentration 
• MEM (GIBCO, 61100-061) 2 pack N/A 
• Sodium bicarbonate (NaHCOs) (Sigma, S2127, FW 106.0)4.4 g 0.22 % (W/V) 
Adjust pH to 7.50，0.22 [im filter and store at 4 
10 X Phosphate-buffered saline (PBS): ^ working concentration 
• Sodium Chloride (NaCl) (Sigma, S9888, FW 58.44) 160 g 137 mM 
• Potassium chloride (KCl) (Sigma, P4504, FW 74.55) 4 g 2.7 mM 
• Sodium Phosphate, dibasic, anhydrous 
(Na2HP04) (Sigma, S0876, FW 141.96) 12.2g 4.3 mM 
• Potassium Phosphate, monobasic, anhydrous 
(KH2PO4) (Sigma, P5379, FW 136.1) 4 g 1.4 mM 
Adjust^pH to 7.4 and store at room temperature. 
Propidium iodide stock solution S 10 ml working concentration 
• Propidium iodide (Sigma, P4170, FW668.4) 25 mg 50 ng/ml 
• I X PBS 10 ml N/A 
Aliquot to 400 ^1/vial and store at -20 in dark. 
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Ribonuclease A stock solution I 10ml working concentration 
• Ribonuclease A (RNase A) (Sigma, R4875, MW 13,700) 1 g 0.1 % (W/V) 
• I X PBS 10 ml N/A 
Aliquot to 200 |al/vial and store at -20 
5.1.2 Detection of mitogenic activity of human bone marrow stromal cells on 
the selected cell line, SK-Hep-1 cells 
Equipment or reagent Supplier Code no. 
Spectrophotometer Beckman DU650 
Ultracentrifiige Beckman Instruments, Inc. XL-70 
Ultrasonic Processor Cole-Parmer Instrument Co. torbeo 36800 
Bovine serum albumin standard stock solution S 10 ml Final concentration 
• Bovine serum albumin (BSA) (Sigma, A2153) 20 mg 2 mg/ml 
Aliquot to 50 |al/vial and store at -20 °C. 
Pipette 30 |il bovine serum albumin standard stock solution to 270 pi Milli-Q before use. 
RPMI medium 1640 I 2 L working concentration 
• RPMI medium 1640 (GIBCO, 23400-021) 1 pack N/A 
• Sodium bicarbonate (NaHCOa) (Sigma, S2127’ FW106.0)4 g 0.2 % (W/V) 
Adjust pH to 7.50，0.22 \im filter and store at 4 
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Standard curve 
Prepare the standard curve and measure the sample as following table: 
Concentration H2O BSA STD / Solvent used in Dye Reagent Concentrate 
(^^g/ml) (nl) sample (nl) sample (jil) (Bio-Rad, 500-0006) (}il) 
~0 ^ 0 10 ^ 
"5 ^ Ys 10 ^ 
~10 ^ 10 ^ ‘ 
~15 1V5 75 10 ^ ‘ 
^ 10 ^ 
Sample 10 / ^ “ 
5.1.3 Characterization of hepatocyte mitogenic activity of bone marrow stromal 
cellular extract 
Equipment or reagent Supplier Code no. 
Dialysis tubings MWCO 3.5 kDa Spectrum Laboratories Inc. 132720 
Dialysis tubings MWCO 14 kDa Spectrum Laboratories Inc. 132676 
Endoproteinase Lys-C Roche 1047825 
TLCK Roche 874493 
Trypsin Roche 1418025 
0.1 M EDTA solution I 2 L working concentration 
• 0.5 M EDTA stock solution 400 ml 0.1 M 
Store a|- room temperature. 
0.5 M EDTA stock solution £ 500 ml Working concentration 
• Ethylenediaminetetraacetic acid (EDTA) 
(Sigma, E6511，FW380.2) 95.05 g 0.5 M 
Store at room temperature. 
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Sodium bicarbonate / EDTA solution S 2 L working concentration 
• 0.5 M EDTA stock solution 4 ml 1 mM 
• Sodium bicarbonate (NaHCOs) (Sigma, S2127, FW 106.0)40 g 2 % 
Store at room temperature. 
5.1.4 Performing a preliminary test on the difference between bone marrow 
stromal cellular extract and other growth factors 
Equipment or reagent Supplier Code no. 
32Pi，0.1 mCi/ml, carrier free Pharmacia PBS 11 -1 OmCi 
Automated Gel Stainer Pharmacia 80-6395-02 
BioMax MR autoradiography film Eastman Kodak Company 8912560 
EN'HANCE NEN™ NEF981 
ExcelGel SDS Pharmacia 80-1255-53 
Gel Dryer Bio-Rad 583 
Immobiline DryStrip Kit Pharmacia 18-1004-30 
Immobiline DryStrip Reswelling Tray Pharmacia 80-6371-84 
IPG Cover Fluid Pharmacia 17-1335-01 
IPG Strip, pH 3 - 10 linear, 11 cm Pharmacia 18-1016-61 
Labeling medium, phosphate free DMEM GIBCO-BRL Life Technologies 11971-025 
Multi Temp III Thermostatic Circulator Pharmacia 18_ 1102-78 
Multiphor II unit Pharmacia 18-1018-06 
PlusOne Silver Staining Kit, Protein Pharmacia 17_ 115o_o l 
Power ^ supply Pharmacia EPS 3501 XL 
Two-dimensional SDS-PAGE standards Bio-Rad 161-0320 
Developing solution S 1250 ml working concentration 
• Sodium carbonate (Pharmacia, 17-1150-01，FW 106.0) 31.25 g 2.5 % (W/V) 
Store at room temperature. 
Add 35 [i\ 37 % formaldehyde (Pharmacia, 17-1150-01) to 175 ml developing solution before use. 
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Epidermal growth factor stock solution 1000 Final concentration 
• EGF (Calbiochem, 324831) 200 |ig 200 ng/^il 
• IX PBS 1000 Hi N/A 
Aliquot to 10 jil/vial and store at -80 "C; 100 X dilution to 2 ng/^il before use. 
Fixer solution m . working concentration 
• Glacial acetic acid (Riedel-de Haen, 27225, FW60.05) 100 ml 10%(VA^) 
• Absolute ethanol (Riedel-de Haen, 32221, FW46.07) 400 ml 40 % (V/V) 
Store at room temperature. 
Hepatocyte growth factor stock solution 500 i^l Final concentration 
• H G F (Calbiochem, 375228) 5 |IG lOng/pl 
• I X PBS 500 Ml N/A 
Aliquot to 30 f^l/vial and store at -80 
Insulin stock solution ^ m l Final concentration 
• insulin (Calbiochem, 407694) 50 mg 1 mg/ml 
• I X PBS 50 ml N/A 
Aliquot to 1 ml/vial and store at -80 
Lysis solution: S4Qml working concentration 
• Urea (Sigma, U1250, FW60.06) 19.2 g 8 M 
• Triton X-100 (Sigma, X-100) 1.6 g 4 % (W/V) 
• Trizma base (Tris base) (Sigma, T1410’ FW121.1) 0.194 g 40 mM 
• DL-Dithiothreitol (DL-DTT) (Sigma, D0632, FW 154.2) 0.123 g 20 mM 
Aliquot to 300 jiil/vial and store at -20 '^ C. 
Preserving solution I_LL working concentration 
• Glycerol (Sigma, G7757，FW92.09) 87 ml 8.7 % (V/V) 
Store at room temperature. 
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Rehydration stock solution with IPG buffer: S 25 ml working concentration 
• Urea (Sigma, U1250, FW60.06) 12 g 8M 
• Triton X-100 (Sigma, X-100) 0.5 g 2 % (WA^) 
• IPG Buffer pH3-10L (Pharmacia, 17-6000-87) 125 \x\ 0.5 % 
• Bromophenol blue (Sigma, B6131, FW691.9) a few grains trace 
• DL-Dithiothreitol (DL-DTT) (Sigma, D0632, FW 154.2) 75 mg 0 .3% 
Aliquot to 200 jil/vial and store at —20 °C. 
SDS equilibration buffer with DTT / iodoacetamide S 200 ml working concentration 
• 0.5 M Tris-HCl stock solution 20 ml 0.1 M 
• Urea (Sigma, U1250, FW60.06) 72 g 6 M 
• Glycerol (Sigma, G7757, FW92.09) 60 ml 30 % (V/V) 
• Sodium dodecyl sulfate (SDS) (Sigma, L4509, FW288.4) 2 g 1 % (w/V) 
• Bromophenol blue (Sigma, B6131, FW691.9) a few grains trace 
iodoacetamide only 
• DL-Dithiothreitol (DL-DTT) (Sigma, D0632, FW 154.2) / 1 g / 0.5 % (W/V) / 
Iodoacetamide (Sigma, II149，FW185.0) 9 g 4.5 % (w/V) 
Aliquot to 10 ml/vial and store at -20 
Sensitizing solution 1 1250 ml working concentration 
• Sodium acetate (Pharmacia, 17-1150-01’ FW 136.1) 85 g 6.8 % (W/V) 
• 5 % sodium thiosulfate 
(Pharmacia, 17-1150-01，FW 158.1) 50 ml 0.2 % (W/V) 
• Al^solute ethanol (Riedel-de Haen, 32221, FW46.07) 375 ml 30 % (V/V) 
Store at room temperature. 
Add 0.875 ml 25 % glutardialdehyde (Pharmacia, 17-1150-01) to 175 ml sensitizing solution before 
use. 
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Silver solution S 1250 ml working concentration 
• 2.5 % silver nitrate solution (Pharmacia, 17-1150-01) 125 ml 0.25 % (W/V) 
Store in dark at room temperature. 
Add 70 \x\ 37 % formaldehyde (Pharmacia, 17-1150-01，FW30.03) to 175 ml silver solution before use. 
Stop solution I： 1250 ml working concentration 
• EDTA - Na2 (Pharmacia, 17-1150-01, FW380.2) 18.25 g 1.46 % (W/V) 
Store at room temperature. 
Transforming growth factor-a stock solution 500 i^l Final concentration 
• TGF-a (Calbiochem, 616430) 100 |ig 200 ng/^il 
• IX PBS 500^11 N/A 
Aliquot to 10 |il/vial and store at -80 100 X dilution to 2 ng/|al before use. 
0.5MTris-HCL stock solution S 500 ml working concentration 
• Trizma base (Tris base) (Sigma, T1410, FW121.1) 30.5 g 0.5 M 
First dissolve in 300 ml H2O. Add 19 ml 37 % concentrated HCl and then adjust pH slowly with 1 N 
HCl to 6.8. Filter and store at 4 
20mMTris-HCl stock solution: ^ working concentration 
• Trizma base (Tris base) (Sigma, T1410，FW 121.1) 24.22g 20mM 
Adjust pH to 7.50 after 10 fold dilution and store at room temperature. 
i 
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